Artelo Biosciences, Inc. (ARTL) Press Releases https://ir.artelobio.com/news-events/press-releases/rss en-us https://d1io3yog0oux5.cloudfront.net/artelobio/files/theme/images/logo-sm.png Artelo Biosciences, Inc. Logo Equisolve Investor Relations Suite <![CDATA[New Analysis of Over 50 Studies Showed that All the Non-Prescription CBD Products Researched Fell Short of Therapeutic Efficacy — Reinforcing the Case for Artelo's Optimized ART12.11 CBD Composition]]> https://ir.artelobio.com/news-events/press-releases/detail/195/new-analysis-of-over-50-studies-showed-that-all-the Wed, 22 Jul 26 08:39:00 -0400 https://ir.artelobio.com/news-events/press-releases/detail/195/new-analysis-of-over-50-studies-showed-that-all-the <![CDATA[Artelo Biosciences Announces Results from a Nonclinical Osteoarthritis Study Supporting ART26.12 as a Potential First-in-Class New Therapy for Chronic Pain Conditions]]> https://ir.artelobio.com/news-events/press-releases/detail/194/artelo-biosciences-announces-results-from-a-nonclinical Thu, 16 Jul 26 08:48:00 -0400 https://ir.artelobio.com/news-events/press-releases/detail/194/artelo-biosciences-announces-results-from-a-nonclinical <![CDATA[Artelo Biosciences Issues Reminder to Shareholders to Vote in Advance of Annual Meeting on July 17, 2026]]> https://ir.artelobio.com/news-events/press-releases/detail/193/artelo-biosciences-issues-reminder-to-shareholders-to-vote Tue, 14 Jul 26 08:47:00 -0400 https://ir.artelobio.com/news-events/press-releases/detail/193/artelo-biosciences-issues-reminder-to-shareholders-to-vote <![CDATA[Artelo Biosciences Announces Positive Results with ART27.13 in a Nonclinical Model of Paclitaxel-Induced Peripheral Neuropathy]]> https://ir.artelobio.com/news-events/press-releases/detail/192/artelo-biosciences-announces-positive-results-with-art27-13 Mon, 13 Jul 26 09:02:00 -0400 https://ir.artelobio.com/news-events/press-releases/detail/192/artelo-biosciences-announces-positive-results-with-art27-13 <![CDATA[Artelo Biosciences Announces New Data Supporting ART26.12 as a Potential First-in-Class Therapy for Chronic Pain associated with Spinal Cord Injury]]> https://ir.artelobio.com/news-events/press-releases/detail/191/artelo-biosciences-announces-new-data-supporting-art26-12 Wed, 01 Jul 26 08:42:00 -0400 https://ir.artelobio.com/news-events/press-releases/detail/191/artelo-biosciences-announces-new-data-supporting-art26-12 <![CDATA[Artelo Biosciences Presents Evidence for a Common Lipid-Signaling Link Across Multiple Potential Indications for Its FABP5 Inhibitor Platform at ICRS 2026]]> https://ir.artelobio.com/news-events/press-releases/detail/190/artelo-biosciences-presents-evidence-for-a-common Tue, 30 Jun 26 08:57:00 -0400 https://ir.artelobio.com/news-events/press-releases/detail/190/artelo-biosciences-presents-evidence-for-a-common <![CDATA[Artelo Biosciences Presents Clinical and Biomarker Data Supportive of the Development of ART26.12 and Follow-On FABP5 Inhibitors at ICRS 2026]]> https://ir.artelobio.com/news-events/press-releases/detail/189/artelo-biosciences-presents-clinical-and-biomarker-data Mon, 29 Jun 26 08:45:00 -0400 https://ir.artelobio.com/news-events/press-releases/detail/189/artelo-biosciences-presents-clinical-and-biomarker-data <![CDATA[Artelo Biosciences Presents ART26.12 Human Metabolite Data Demonstrating Favorable Drug Metabolism Characteristics Associated with Clinical Development Success]]> https://ir.artelobio.com/news-events/press-releases/detail/188/artelo-biosciences-presents-art26-12-human-metabolite-data Wed, 10 Jun 26 07:38:00 -0400 https://ir.artelobio.com/news-events/press-releases/detail/188/artelo-biosciences-presents-art26-12-human-metabolite-data <![CDATA[Artelo Biosciences Provides Business Update Outlining Upcoming Milestones and Reports 2026 First Quarter Financial Results]]> https://ir.artelobio.com/news-events/press-releases/detail/187/artelo-biosciences-provides-business-update-outlining Thu, 14 May 26 16:05:00 -0400 https://ir.artelobio.com/news-events/press-releases/detail/187/artelo-biosciences-provides-business-update-outlining <![CDATA[Artelo Biosciences Announces Strategic Collaboration with Artificial Intelligence (AI) Leader ScienceMachine Highlighting New Expansion Opportunities and Insights for FABP5 Inhibitor Development]]> https://ir.artelobio.com/news-events/press-releases/detail/186/artelo-biosciences-announces-strategic-collaboration-with Tue, 28 Apr 26 08:25:00 -0400 https://ir.artelobio.com/news-events/press-releases/detail/186/artelo-biosciences-announces-strategic-collaboration-with